Lv11
70 积分 2025-04-18 加入
Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial
1小时前
已关闭
Cancer vaccines: the experts speak
12天前
已完结
Sacituzumab Tirumotecan in Participants With Advanced or Metastatic Urothelial Carcinoma and Disease Progression after Chemotherapy and Immune Checkpoint Inhibitors
19天前
已完结
TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial
1个月前
已完结
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutation
1个月前
已完结
Proton Therapy for Spinal Tumors: A Consensus Statement from the Particle Therapy Cooperative Group
1个月前
已关闭
Proton Therapy for Spinal Tumors: A Consensus Statement from the Particle Therapy Cooperative Group
1个月前
已关闭
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
1个月前
已完结
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
1个月前
已关闭
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
1个月前
已完结
皖公网安备34019202002308
